Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

Immune Modulatory Therapies LLC
Profile last edited on: 1/24/20      CAGE: 7F0L2      UEI: J453G5R8UMJ5

Business Identifier: Therapies that modulate the body's immune system
Year Founded
2015
First Award
2018
Latest Award
2021
Program Status
Active
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

4786 ENSER RD
Eden, NY 14057
   (716) 713-5772
   N/A
   www.immunemodulatorytherapies.us
Location: Single
Congr. District: 27
County: Erie

Public Profile

Immune Modulatory Therapies LLC is developing therapies that modulate the body's immune system. The firm's technologies reduce the body's immune response to specific tissues, thus reducing the effect of autoimmune diseases. The firm also is working on modulating the body's response to specific drugs, making these drugs less toxic and more effective over time.

Extent of SBIR involvement

User Avatar
Phase I Awards
2
Phase II Awards
0
Conversion Rate
0.00%
Phase I Dollars
$574,106
Phase II Dollars
$0
Total Awarded
$574,106

Synopsis: Awardee Business Condition

Employee Range
5-9
Revenue Range
.5M-1M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2021 1 NIH $293,178
Project Title: Novel Drug for Cancer Immunotherapy that Targets Phosphatidylserine
2018 1 NIH $280,928
Project Title: Reversing/Blocking T Cell Suppression by Extracellular Vesicles as Cancer Therapy

Key People / Management

  Maulasri Bhatta

Company News

There are no news available.